Compare Nokia Corp (NOK) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs Novartis AG — how do they compare? Nokia Corp trades at $10.2 (market cap $53.00B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 5.6× Nokia Corp's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| NOK | NVS | |
|---|---|---|
Market Cap | $53.00B | $295.37B |
Sector | Technology | Health |
52-Week High | $16.83 | $168.62 |
52-Week Low | $4.13 | $119.31 |
Enterprise Value | $50.95B | $336.69B |
Dividend Yield | 1.73% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
